Hi 99…
Firstly I have to say I am not trying to discredit you for the sake of doing so, but there are a few aspects that I cannot let pass … please take this post in good faith.
“there is a probability of a higher offer”…. “ a probability the offer falls through during DD”… “and most likely a higher probability of the deal at current valuation”.
As Merck have been conducting Clinical Trials with Cavatak and have been on board with VLA for over a year, they will likely be in possession of more Trial data than the VLA Board.
The DD has certainly been done and dusted many moons ago. So the ‘probability’ gravitates to below ‘possibility’…. to zero.
There is no inclusion in the Offer document referring to DD.
“it is highly UNLIKELY you WONT get a whiff of a NO vote."
I had to wrestle with that a bit and sense you are saying there is little chance of a “no” vote. “sell your position and put the cash against your home loan (opportunity cost).”
Well… 6% in 3 months (7cents) is better than 6% in 12 months (Overdraft).
“please don’t try and scare the mob”…. To those who may have ADDED to their position as a result of the “probability(possibility?) you are in effect, inadvertently, “scaring the mob” by referring to ” the probability of deal falling over during DD.”
Just trying to maintain clearer perspective.
VLA Price at posting:
$1.68 Sentiment: Hold Disclosure: Held